Johnson & Johnson will pay $6.5 billion to resolve nearly all talc ovarian cancer lawsuits in U.S.

Breaking News: Business News

Johnson & Johnson will pay $6.5 billion to resolve nearly all talc ovarian cancer lawsuits in U.S.
Johnson & JohnsonHealth Care IndustryPharmaceuticals
  • 📰 CNBC
  • ⏱ Reading Time:
  • 16 sec. here
  • 9 min. at publisher
  • 📊 Quality Score:
  • News: 34%
  • Publisher: 72%

The deal would allow J&J to resolve the lawsuits through a third bankruptcy filing of a subsidiary company, LTL Management.

Johnson & Johnson said it will pay $6.5 billion to settle nearly all of the thousands of lawsuits in the U.S. claiming its talc-based products caused ovarian cancer.

J&J said the remaining pending lawsuits relate to a rare cancer called mesothelioma and will be addressed ouside of the new settlement plan.on Wednesday said it will pay $6.5 billion to settle nearly all of the thousands of lawsuits in the U.S. claiming its talc-based products caused ovarian cancer.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

CNBC /  🏆 12. in US

Johnson & Johnson Health Care Industry Pharmaceuticals Biotech And Pharmaceuticals Biotechnology Business Business News

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

NBA legend Magic Johnson points finger at load management after Lakers' early playoff exitNBA legend Magic Johnson points finger at load management after Lakers' early playoff exitThe Denver Nuggets may have simply been the better basketball team, but NBA legend Magic Johnson says he has identified the reason for the Lakers' early playoff exit.
Read more »

Aaron Taylor-Johnson and Sam Taylor-Johnson Relationship TimelineAaron Taylor-Johnson and Sam Taylor-Johnson Relationship TimelineGina Vivinetto is a writer for TODAY.com.
Read more »

Johnson & Johnson Sells Off Ahead of Earnings: Time to Cut Losses or Double Down?Johnson & Johnson Sells Off Ahead of Earnings: Time to Cut Losses or Double Down?Stocks Analysis by Investing.com (Damian Nowiszewski) covering: Johnson & Johnson, Netflix Inc, ABIOMED Inc. Read Investing.com (Damian Nowiszewski)'s latest article on Investing.com
Read more »

Johnson & Johnson to Acquire Shockwave Medical for $13 BillionJohnson & Johnson to Acquire Shockwave Medical for $13 BillionJohnson & Johnson is investing $13 billion in Shockwave Medical, a company specializing in technology for opening clogged arteries. The deal involves cash acquisition and will help expand heart care services. Shockwave uses intravascular lithotripsy technology to crack calcium lesions in arteries and restore blood flow.
Read more »

Johnson & Johnson to Acquire Shockwave Medical in $13 Billion DealJohnson & Johnson to Acquire Shockwave Medical in $13 Billion DealJohnson & Johnson is pumping more money into heart care with a roughly $13 billion deal for Shockwave Medical, which specializes in technology that helps open clogged arteries.
Read more »

Johnson & Johnson to Acquire Shockwave Medical in $13 Billion DealJohnson & Johnson to Acquire Shockwave Medical in $13 Billion DealJohnson & Johnson is pumping more money into heart care with a roughly $13 billion deal for Shockwave Medical, which specializes in technology that helps open clogged arteries.
Read more »



Render Time: 2025-04-06 15:04:37